ME/CFS screening questionnaire
The DSQ-Brief: a 4-item self-check
This is a free, interactive version of the DSQ-Brief, a short screening scale for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) developed by Leonard Jason and colleagues at DePaul University and published in 2023. It was drawn from the much longer DePaul Symptom Questionnaire: the authors picked the four symptom questions that identify people who meet the Institute of Medicine (IOM) case definition for ME/CFS.
Those four items cover fatigue, tiredness after minimal exercise (a sign of post-exertional malaise), unrefreshing sleep and memory problems. In the validation study of 3,427 people, the four questions told people with ME/CFS apart from healthy controls with 96% accuracy (94% sensitivity, 98% specificity).
It is intended for anyone with persistent fatigue, a post-viral illness, or suspected ME/CFS who wants a quick, structured self-check before deciding whether to look into things further. It takes under two minutes. Answer each item for how it has been over the past six months, and you will get an immediate result with a per-symptom breakdown. No sign-up or email is required, and nothing you enter leaves your device. To characterise your post-activity symptom pattern in more depth, the DSQ-PEM adds recovery time and triggers; for the complete assessment, take the full DSQ-2.
Your DSQ-Brief result
Symptom breakdown
| Symptom | Frequency | Severity | Score | Threshold |
|---|
Score is a 0–100 composite: (frequency + severity) ÷ 2 × 25. The threshold column shows whether the symptom met the 2/2 rule (both frequency and severity rated 2 or higher).
Why the full questionnaire matters
The DSQ-Brief does well at telling ME/CFS apart from health: 96% accuracy against healthy controls in its validation study. Against a group with other illnesses that also cause fatigue (long COVID, multiple sclerosis or post-polio syndrome), accuracy fell to 84%. Four questions can only tell you so much.
The full DePaul Symptom Questionnaire (DSQ-2) captures symptoms across eight domains, including orthostatic intolerance, cognitive impairment, pain, sleep disruption, and immune and temperature symptoms. Together these build a far more complete picture. In the same study, the longer DSQ-1 (54 items) and DSQ-SF (14 items) reached 94% and 93% accuracy against the other illnesses, and the authors suggest following the DSQ-Brief with a longer questionnaire.
If you have time for something longer, the full version asks all 79 DSQ-2 symptom questions and checks your answers against four ME/CFS case definitions, which gives you a detailed record to take to a clinical appointment.
Take the full DSQ-2 questionnaire →How the verdict is worked out, and how accurate the screen is, is explained below the results. If your symptoms clearly worsen in the hours or days after activity that used to be manageable, that is worth raising with a clinician whatever this screen says.
This result is not a diagnosis. It reflects what you have reported about your own symptoms. Discuss it with your doctor or specialist.
Your results over time
Complete this again in a few weeks and the change will show here.
Symptom scores change slowly. A monthly retake is enough to see a trend.
Your results are stored only in this browser, on this device. Nothing is sent to us or to anyone else. They will be lost if you clear this site's data, use a private window, or switch browser or device. You can delete them at any time.
Understanding your DSQ-Brief result
What the score measures
The DSQ-Brief is a 4-question screen for ME/CFS from DePaul University, published by Jason, Benner, Furst and Cathey in 2023. It asks how often and how severely you have had fatigue, physical tiredness after minimal exercise, unrefreshing sleep and problems remembering things over the past six months. The four questions were chosen to pick out people who meet the Institute of Medicine (IOM) case definition for ME/CFS.
The wording follows DePaul's published form (DSQ-Brief form (DePaul)). Each symptom's 0 to 100 score combines frequency and severity, as DePaul does in its research; it is for tracking and has no cut-off.
Score bands
Each symptom is rated for frequency and severity from 0 to 4. As in DePaul's other questionnaires, a symptom counts when both are 2 or more: at least half the time and at least moderate. The paper tested the four questions with a statistical model rather than a simple cut-off, so the rule for a positive screen here is this site's own: all four symptoms must count.
The 2/2 rule is the one DePaul uses elsewhere (Cotler et al. 2018), and the four symptoms line up with the four NICE needs before ME/CFS is suspected: fatigue worsened by activity, post-exertional malaise, unrefreshing sleep and cognitive difficulties (NICE NG206).
In the validation study of 3,427 people, the DSQ-Brief told people with ME/CFS apart from healthy controls with 96% accuracy (94% sensitivity, 98% specificity). Against a group with long COVID, multiple sclerosis or post-polio syndrome, accuracy fell to 84% (85% sensitivity, 81% specificity). The authors suggest following it with a longer DePaul questionnaire.
| Questionnaire | ME/CFS vs healthy controls | ME/CFS vs other illnesses |
|---|---|---|
| DSQ-Brief (4 items) | 96 / 94 / 98 | 84 / 85 / 81 |
| DSQ-SF (14 items) | 98 / 97 / 99 | 93 / 93 / 94 |
| DSQ-1 (54 items) | 99 / 98 / 99 | 94 / 95 / 94 |
These figures come from a statistical model, not from this page's 4-of-4 rule, so they describe the four questions rather than this page's verdict.
What a change in score means
No minimal important change has been published. The questions cover the past six months, so repeat it every few months rather than weekly, and watch whether the number of symptoms at the threshold changes rather than small shifts in the 0 to 100 item scores.
What it does not measure
No. A positive screen means your answers match the four symptoms the screen looks for. It is less accurate at telling ME/CFS apart from other illnesses that cause fatigue, and a diagnosis needs a clinician to assess you and rule out other causes. A negative screen does not rule ME/CFS out either.
It does not cover orthostatic intolerance, pain or how long you have been ill. The DSQ-PEM looks at post-exertional malaise in depth, and the DSQ-2 checks four ME/CFS case definitions.
Taking this to your GP or consultant
Bring the date, the verdict, which symptoms met the threshold, and any earlier results. Describe it as a 4-question screen from the DePaul Symptom Questionnaire, published in 2023. NICE says ME/CFS should be suspected when all four core symptoms have lasted 6 weeks in an adult whose activity has dropped markedly, and diagnosed only after 3 months and an assessment for other causes. A positive screen is a reason to ask for that assessment, not evidence of ME/CFS on its own. See preparing for a GP appointment.
Sources
- Jason LA, Benner S, Furst J, Cathey P. Developing and validating a brief screening scale for ME/CFS. Fatigue: Biomedicine, Health & Behavior 2023;11(2–4):176–87. Article (paywalled)
- ME Research UK. Can a brief screening scale accurately detect ME/CFS? Research summary. ME Research UK summary
- DePaul University. DePaul Symptom Questionnaire – Brief. DSQ-Brief form (DePaul)
- Cotler J, Holtzman C, Dudun C, Jason LA. A brief questionnaire to assess post-exertional malaise. Diagnostics 2018;8(3):66, Appendix B. Full text
- National Institute for Health and Care Excellence. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NG206). 2021. Guideline